These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32891161)

  • 21. Call to Action: SARS-CoV-2 and CerebrovAscular DisordErs (CASCADE).
    Abootalebi S; Aertker BM; Andalibi MS; Asdaghi N; Aykac O; Azarpazhooh MR; Bahit MC; Barlinn K; Basri H; Shahripour RB; Bersano A; Biller J; Borhani-Haghighi A; Brown RD; Campbell BC; Cruz-Flores S; De Silva DA; Di Napoli M; Divani AA; Edgell RC; Fifi JT; Ghoreishi A; Hirano T; Hong KS; Hsu CY; Huang JF; Inoue M; Jagolino AL; Kapral M; Kee HF; Keser Z; Khatri R; Koga M; Krupinski J; Liebeskind DS; Liu L; Ma H; Maud A; McCullough LD; Meyer DM; Mifsud V; Morovatdar N; Nilanont Y; Oxley TJ; Özdemir AÖ; Pandian J; Pantoni L; Papamitsakis NIH; Parry-Jones A; Phan T; Rodriguez G; Romano JG; Sabaa-Ayoun Z; Saber H; Sasannezhad P; Saver JL; Scharf E; Shuaib A; Silver B; Singhal S; Smith CJ; Stranges S; Sylaja PN; Torbey M; Toyoda K; Tsivgoulis G; Wasay M; Yassi N; Yoshimoto T; Zamani B; Zand R
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):104938. PubMed ID: 32807412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imported COVID-19 cases pose new challenges for China.
    Chen L; Cai J; Lin Q; Xiang B; Ren T
    J Infect; 2020 Jun; 80(6):e43-e44. PubMed ID: 32283157
    [No Abstract]   [Full Text] [Related]  

  • 23. Considerations in the Triage of Urologic Surgeries During the COVID-19 Pandemic.
    Stensland KD; Morgan TM; Moinzadeh A; Lee CT; Briganti A; Catto JWF; Canes D
    Eur Urol; 2020 Jun; 77(6):663-666. PubMed ID: 32279903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19): structured summary of a study protocol for a randomized controlled trial.
    Zhang S; Lv Z; Zhu Q; Sun W; Yao F; Fang L; Cheng Y; Wu Z; Fang M
    Trials; 2020 May; 21(1):416. PubMed ID: 32446311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Laboratory Risk Assessment during the Coronavirus (COVID-19) Pandemic.
    Nichols JH; Rauch CA
    J Appl Lab Med; 2020 Jul; 5(4):808-811. PubMed ID: 32529229
    [No Abstract]   [Full Text] [Related]  

  • 26. Fast, portable tests come online to curb coronavirus pandemic.
    Sheridan C
    Nat Biotechnol; 2020 May; 38(5):515-518. PubMed ID: 32203294
    [No Abstract]   [Full Text] [Related]  

  • 27. The CREST-2 experience with the evolving challenges of COVID-19: A clinical trial in a pandemic.
    Meschia JF; Barrett KM; Brown RD; Turan TN; Howard VJ; Voeks JH; Lal BK; Howard G; Brott TG
    Neurology; 2020 Jul; 95(1):29-36. PubMed ID: 32358216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroendovascular clinical trials disruptions due to COVID-19. Potential future challenges and opportunities.
    Rai AT; Leslie-Mazwi TM; Fargen KM; Pandey AS; Dabus G; Hassan AE; Fraser JF; Hirsch JA; Gupta R; Hanel R; Yoo AJ; Bozorgchami H; Fiorella D; Mocco J; Arthur AS; Zaidat O; Siddiqui AH
    J Neurointerv Surg; 2020 Sep; 12(9):831-835. PubMed ID: 32606103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 hits a trial: Arguments against hastily deviating from the plan.
    Großhennig A; Koch A
    Contemp Clin Trials; 2020 Nov; 98():106155. PubMed ID: 32961360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-COVID-19 UK clinical trials and the COVID-19 pandemic: impact, challenges and possible solutions.
    Lorenc A; Rooshenas L; Conefrey C; Wade J; Farrar N; Mills N; Paramasivan S; Realpe A; Jepson M
    Trials; 2023 Jun; 24(1):424. PubMed ID: 37349850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of pharmacovigilance during the COVID-19 pandemic crisis by the safety department of an academic sponsor: Lessons learnt and challenges from the EU DisCoVeRy clinical trial.
    Mercier N; Belhadi D; DeChanet A; Delmas C; Saillard J; Dumousseaux M; Le Mestre S; Fougerou-Leurent C; Ferrane A; Burdet C; Espérou H; Ader F; Hites M; Peiffer-Smadja N; Poissy J; Andrejak C; Paiva JA; Tacconelli E; Staub T; Greil R; Costagliola D; Mentre F; Yazdanpanah Y; Diallo A;
    Pharmacol Res Perspect; 2023 Jun; 11(3):e01072. PubMed ID: 37269068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Operational challenges and mitigation measures during the COVID-19 pandemic-Lessons from DELIVER.
    Bhatt AS; Lindholm D; Nilsson A; Zaozerska N; Claggett BL; Vaduganathan M; Kosiborod MN; Lam CSP; Hernandez AF; Martinez FA; Inzucchi SE; Shah SJ; de Boer RA; Desai A; Jhund PS; Langkilde AM; Petersson M; McMurray JJV; Solomon SD
    Am Heart J; 2023 Sep; 263():133-140. PubMed ID: 37220822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A risk assessment tool for resumption of research activities during the COVID-19 pandemic for field trials in low resource settings.
    Simkovich SM; Thompson LM; Clark ML; Balakrishnan K; Bussalleu A; Checkley W; Clasen T; Davila-Roman VG; Diaz-Artiga A; Dusabimana E; Fuentes LL; Harvey S; Kirby MA; Lovvorn A; McCollum ED; Mollinedo EE; Peel JL; Quinn A; Rosa G; Underhill LJ; Williams KN; Young BN; Rosenthal J;
    BMC Med Res Methodol; 2021 Apr; 21(1):68. PubMed ID: 33845785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managing clinical trials during COVID-19: experience from a clinical research facility.
    Shiely F; Foley J; Stone A; Cobbe E; Browne S; Murphy E; Kelsey M; Walsh-Crowley J; Eustace JA
    Trials; 2021 Jan; 22(1):62. PubMed ID: 33461595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trials in urological oncology: COVID-19 and the potential need for a new perspective.
    Teh J; O'Connor E; Coles-Black J; Lawrentschuk N
    World J Urol; 2021 Sep; 39(9):3147-3149. PubMed ID: 32886143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges and Lessons Learned From COVID-19 Trials: Should We Be Doing Clinical Trials Differently?
    Janiaud P; Hemkens LG; Ioannidis JPA
    Can J Cardiol; 2021 Sep; 37(9):1353-1364. PubMed ID: 34077789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suspension of Oncology Randomized Clinical Trials during the COVID-19 Pandemic: A Cross-Sectional Evaluation of COVID-Related Suspensions.
    Sayyid RK; Hiffa A; Woodruff P; Oberle MD; Lambert JH; Terris MK; Wallis CJD; Klaassen Z
    Cancer Invest; 2022 Oct; 40(9):743-749. PubMed ID: 35852930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using virtual multiteam systems to conduct a multisite randomized clinical trial in the part C early intervention system: Benefits, challenges, and lessons learned.
    Ingersoll B; Espinel A; Nauman J; Broder-Fingert S; Carter AS; Sheldrick RC; Stone WL; Wainer AL
    Contemp Clin Trials; 2024 Aug; 143():107585. PubMed ID: 38821261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medicinal cannabis in palliative medicine: lessons learnt from randomised controlled trials.
    Gurgenci T; Hardy J; Olson R; Huggett G; Foster K; Good P
    BMJ Support Palliat Care; 2023 Jun; 13(2):238-240. PubMed ID: 36379690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developing resilient clinical trials: Lessons learned from rolling out the Get Back to Healthy trial during a pandemic.
    Ho EK; Ferreira ML; Hodges P; Halliday M; Maka K; Ceprnja D; Jennings M; Amorim AB; Baysari MT; Ferreira PH
    Contemp Clin Trials; 2023 Oct; 133():107330. PubMed ID: 37652357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.